AF/LE Purified Anti-Human CD44 Antibody[Hermes-1] (E-AB-F12150) elabscience

$50.00
In stock
SKU
E-AB-F12150
SizePrice (USD)
100μg$88.00
100mg$3,214.00
50mg$2,236.00
25mg$1,338.00
5mg$512.00
1mg$142.00

Product Details

AbbreCD44
SynonymsCDw44, Epican, HUTCH-I, LHR, PGP-I
SwissprotP16070
ReactivityHuman
HostRat
ClonalityMonoclonal
CloneHermes-1
IsotypeRat IgG2a, κ
ApplicationsFCM, Block
ConjugationNone (AF/LE)
Concentration≥ 1 mg/mL
BufferSterile PBS, pH 7.2. < 1.0 EU per mg of the antibody as determined by the LAL method.
Research AreasCell Biology, Immunology

Product Description

Background: CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from a low or mid level of intensity to high expression levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Storage and Shipping

StorageStore at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
ShippingIce bag

Additional Information

Verified SamplesVerified Samples in FCM: Human peripheral blood lymphocytes
DilutionFCM 2 μg/mL(0.5×10^6 -1×10^6 cells)
  1. EMF treatment delays mesenchymal stem cells senescence during long-term in vitro expansion by modulating autophagy
    Journal: Frontiers in Cell and Developmental Biology | Year: 2024 | Impact Factor: 4.600
    DOI: 10.3389/fcell.2024.1489774 | Reactivity: Rat | Sample Type: bone marrow mesenchymal stem cell (BMSCs)
  2. Double layer spherical Nanoparticles with Hyaluronic Acid Coating to Enhance Oral Delivery of Exenatide in T2DM rats
    Journal: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | Year: 2023 | Impact Factor: 4.900
    DOI: 10.1016/j.ejpb.2023.09.003 | Reactivity: Human | Sample Type: Caco-2 cell
  3. Doxorubicin intercalated copper diethyldithiocarbamate functionalized layered double hydroxide hybrid nanoparticles for targeted therapy of hepatocellular carcinoma
    Journal: Biomaterials Science | Year: 2019 | Impact Factor: 5.251
    DOI: 10.1039/C9BM01394F | Reactivity: Human | Sample Type: Cell sample

Reviews

Write Your Own Review
You're reviewing:AF/LE Purified Anti-Human CD44 Antibody[Hermes-1] (E-AB-F12150) elabscience
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.